Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar and Collaborators Announce Publication in Blood Advances of Preclinical Data Demonstrating NKTR-255, a Novel Polymer-conjugated Human IL-15, Improves Efficacy of CD19-targeted CAR-T Cell Immunotherapy Nov 09, 2022 Nektar Therapeutics Reports Third Quarter 2022 Financial Results Nov 03, 2022 Nektar to Announce Financial Results for the Third Quarter 2022 on Thursday, November 3, 2022, After Close of U.S.-Based Financial Markets Oct 25, 2022 Nektar Therapeutics Presents Data for Rezpegaldesleukin (LY3471851) in Patients with Atopic Dermatitis and Psoriasis from Two Separate Clinical Studies at 2022 European Academy of Dermatology (EADV) Congress Sep 07, 2022 Nektar and Collaborators Announce Preclinical Publication of Data for NKTR-255 and its Observed Improvement of NK Cell Function in Multiple Myeloma Aug 16, 2022 Nektar Therapeutics Reports Second Quarter 2022 Financial Results Aug 04, 2022 Nektar to Announce Financial Results for the Second Quarter 2022 on Thursday, August 4, 2022, After Close of U.S.-Based Financial Markets Jul 26, 2022 Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial Officer Jul 01, 2022 Nektar Therapeutics Reports First Quarter 2022 Financial Results May 05, 2022 Nektar Therapeutics Announces Strategic Reorganization Plan and Corporate Outlook Apr 25, 2022 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »